UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 54

Sortiert nach

Examination of endobronchial ultrasound-guided transbronchial needle aspiration using a puncture needle with a side trap

Scientific reports, 2021-05, Vol.11 (1), p.9789-9789, Article 9789

2021

Volltextzugriff (PDF)

Minimal contribution of the hepatic uptake transporter OATP1B1 to the inter-individual variability in SN-38 pharmacokinetics in cancer patients without severe renal failure

Cancer chemotherapy and pharmacology, 2021-09, Vol.88 (3), p.543-553

2021

Volltextzugriff (PDF)

Antibiotic Usage Reduced Overall Survival by over 70% in Non-small Cell Lung Cancer Patients on Anti-PD-1 Immunotherapy

Anticancer research, 2021-10, Vol.41 (10), p.4985-4993

2021

Volltextzugriff (PDF)

Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody

Scientific reports, 2024-05, Vol.14 (1), p.11325-11325, Article 11325

2024

Volltextzugriff (PDF)

A case report on severe nivolumab-induced adverse events similar to primary sclerosing cholangitis refractory to immunosuppressive therapy

Medicine (Baltimore), 2021-06, Vol.100 (23), p.e25774

2021

Volltextzugriff (PDF)

Turicibacter and Acidaminococcus predict immune-related adverse events and efficacy of immune checkpoint inhibitor

Frontiers in immunology, 2023-05, Vol.14, p.1164724-1164724

2023

Volltextzugriff (PDF)

Case Report: Combined pembrolizumab, 5-fluorouracil, and cisplatin therapy were remarkably effective in p16-positive squamous cell carcinoma of unknown primary

Frontiers in oncology, 2023-07, Vol.13, p.1231986

2023

Volltextzugriff (PDF)

Variants of carboxylesterase 1 have no impact on capecitabine pharmacokinetics and toxicity in capecitabine plus oxaliplatin treated-colorectal cancer patients

Cancer chemotherapy and pharmacology, 2020-06, Vol.85 (6), p.1119-1128

2020

Volltextzugriff (PDF)

Novel quantitative immunohistochemical analysis for evaluating PD-L1 expression with phosphor-integrated dots for predicting the efficacy of patients with cancer treated with immune checkpoint inhibitors

Frontiers in immunology, 2023-09, Vol.14, p.1260492-1260492

2023

Volltextzugriff (PDF)

Increased Plasma Soluble PD-1 Concentration Correlates with Disease Progression in Patients with Cancer Treated with Anti-PD-1 Antibodies

Biomedicines, 2021-12, Vol.9 (12), p.1929

2021

Volltextzugriff (PDF)

Plasma Levels of Soluble PD-L1 Correlate With Tumor Regression in Patients With Lung and Gastric Cancer Treated With Immune Checkpoint Inhibitors

Anticancer research, 2019-09, Vol.39 (9), p.5195-5201

2019

Volltextzugriff (PDF)

Anti-EGFR antibody monotherapy for colorectal cancer with severe hyperbilirubinemia: A case report

World journal of gastrointestinal oncology, 2024-02, Vol.16 (2), p.557-562

2024

Volltextzugriff (PDF)

PD3-1-3 Utility and role of multigene panel tests for patients with cancer: Retrospective data from a single institution

Annals of oncology, 2021-07, Vol.32, p.S326-S326

2021

Volltextzugriff (PDF)

A case of bronchial asthma as an immune-related adverse event of pembrolizumab treatment for bladder cancer: A case report

Medicine (Baltimore), 2022-01, Vol.101 (2), p.e28339-e28339

2022

Volltextzugriff (PDF)

Nivolumab receptor occupancy on effector regulatory T cells predicts clinical benefit

Cancer science, 2024-03, Vol.115 (3), p.752-762

2024

Volltextzugriff (PDF)

Butyricimonas is a key gut microbiome component for predicting postoperative recurrence of esophageal cancer

Cancer Immunology, Immunotherapy, 2024-01, Vol.73 (2), p.23-23, Article 23

2024

Volltextzugriff (PDF)

High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor prognosis in pancreatic cancer

International journal of oncology, 2021-01, Vol.58 (1), p.57-69

2021

Volltextzugriff (PDF)

Abstract 2146: High expression of Olfactomedin-4 correlates with chemoresistance and poor prognosis for pancreatic cancer

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.2146-2146

2019

Volltextzugriff (PDF)

High expression levels of polymeric immunoglobulin receptor are correlated with chemoresistance and poor prognosis in pancreatic cancer

Oncology reports, 2020-07, Vol.44 (1), p.252-262

2020

Volltextzugriff (PDF)

Rare Nivolumab-associated Super Hyper Progressive Disease in Patients With Advanced Gastric Cancer

In vivo (Athens), 2021-05, Vol.35 (3), p.1865-1875

2021

Volltextzugriff (PDF)

46 Genetic analysis of tumor cells derived from the stress of immune response for understanding of immunotherapy

Journal for immunotherapy of cancer, 2022-11, Vol.10 (Suppl 2), p.A49-A49

2022

Volltextzugriff (PDF)

Abstract 6179: Increased circulating PD-L1 expressing CD14 high CD16 negative classical monocytes correlate with poor prognosis in cancer patients treated with PD-1 blockade therapies

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.6179-6179

2022

Volltextzugriff (PDF)

Anti-EGFR antibody monotherapy for colorectal cancer with severe hyperbilirubinemia: A case report

World journal of gastrointestinal oncology, 2024, Vol.16 (2), p.557-562

2024

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(51)

Publikationsform

Sprache

Englisch
(50)
Japanisch
(17)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Examination of endobronchial ultrasound-guided transbronchial needle aspiration using a puncture needle with a side trap

Minimal contribution of the hepatic uptake transporter OATP1B1 to the inter-individual variability in SN-38 pharmacokinetics in cancer patients without severe renal failure

Antibiotic Usage Reduced Overall Survival by over 70% in Non-small Cell Lung Cancer Patients on Anti-PD-1 Immunotherapy

Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody

A case report on severe nivolumab-induced adverse events similar to primary sclerosing cholangitis refractory to immunosuppressive therapy

Turicibacter and Acidaminococcus predict immune-related adverse events and efficacy of immune checkpoint inhibitor

High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer

Case Report: Combined pembrolizumab, 5-fluorouracil, and cisplatin therapy were remarkably effective in p16-positive squamous cell carcinoma of unknown primary

Variants of carboxylesterase 1 have no impact on capecitabine pharmacokinetics and toxicity in capecitabine plus oxaliplatin treated-colorectal cancer patients

Novel quantitative immunohistochemical analysis for evaluating PD-L1 expression with phosphor-integrated dots for predicting the efficacy of patients with cancer treated with immune checkpoint inhibitors

Increased Plasma Soluble PD-1 Concentration Correlates with Disease Progression in Patients with Cancer Treated with Anti-PD-1 Antibodies

Plasma Levels of Soluble PD-L1 Correlate With Tumor Regression in Patients With Lung and Gastric Cancer Treated With Immune Checkpoint Inhibitors

Anti-EGFR antibody monotherapy for colorectal cancer with severe hyperbilirubinemia: A case report

PD3-1-3 Utility and role of multigene panel tests for patients with cancer: Retrospective data from a single institution

A case of bronchial asthma as an immune-related adverse event of pembrolizumab treatment for bladder cancer: A case report

Nivolumab receptor occupancy on effector regulatory T cells predicts clinical benefit

Non-classical Monocytes Enhance the Efficacy of Immune Checkpoint Inhibitors on Colon Cancer in a Syngeneic Mouse Model

Butyricimonas is a key gut microbiome component for predicting postoperative recurrence of esophageal cancer

High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor prognosis in pancreatic cancer

Abstract 2146: High expression of Olfactomedin-4 correlates with chemoresistance and poor prognosis for pancreatic cancer

High expression levels of polymeric immunoglobulin receptor are correlated with chemoresistance and poor prognosis in pancreatic cancer

Rare Nivolumab-associated Super Hyper Progressive Disease in Patients With Advanced Gastric Cancer

46 Genetic analysis of tumor cells derived from the stress of immune response for understanding of immunotherapy

Abstract 6179: Increased circulating PD-L1 expressing CD14 high CD16 negative classical monocytes correlate with poor prognosis in cancer patients treated with PD-1 blockade therapies

Anti-EGFR antibody monotherapy for colorectal cancer with severe hyperbilirubinemia: A case report

Suchergebnisse filtern